BiSiChem is a leading biotech company that focused on the discovery and
development of innovative therapeutic drugs on immuno-oncology,
targeted therapy and neuro-degenerative diseases.
Our goals are Good lives, Better innovation and Best therapy.
Our main focus is
“BiSiChem is a precision medicine company
developing a specific targeted therapy to treat cancer.”
Breakthrough discovery of therapeutics for unmet medical needs,
biomarker-based innovative, first-in-class or best-in-class candidates development
BiSiChem has a strength on preclinical candidate selection by target selection,
medicinal chemistry, biology and DMPK experties.
R&D Research Center. Pangyo
New Drug Research Center. Yongin
Lifex Biolabs Inc.
Interpark Bio Convergence Corp.
3F, Pangyo-ro 255beon-gil 74,
Gyeonggi-do, Republic of Korea